Sedana Medical AB (publ) (FRA:7D2A)

Market Cap	113.58M -22.3%
Revenue (ttm)	17.65M -0.3%
Net Income	-3.24M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.096
Previous Close	1.040
Day's Range	1.096 - 1.096
52-Week Range	0.668 - 1.416
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1999
• Employees: 117
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7D2A

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error